cupure logo
trumpstarifftariffstrump2025tradegrowthsalesglobalsees

Fat jab wars wipe £70bn off Ozempic maker Novo Nordisk as it feels the heat from rival Eli Lilly

Fat jab wars wipe £70bn off Ozempic maker Novo Nordisk as it feels the heat from rival Eli Lilly
Shares in Novo Nordisk fell as much as 30% after it slashed sales and profits forecasts for the second time this year amid pressure from rival Eli Lilly.

Comments

Business News